Experimental Evidence ofω-3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic Diseases
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
A large body of evidence has emerged over the past years to show the critical role played by inflammation in the pathogenesis of several diseases including some cardiovascular, neoplastic, and neurodegenerative diseases, previously not considered inflammation-related. The anti-inflammatory action ofω-3 polyunsaturated fatty acids (PUFAs), as well as their potential healthy effects against the development and progression of the same diseases, has been widely studied by our and others’ laboratories. As a result, a rethinking is taking place on the possible mechanisms underlying the beneficial effects ofω-3 PUFAs against these disorders, and, in particular, on the influence that they may exert on the molecular pathways involved in inflammatory process, including the production of inflammatory cytokines and lipid mediators active in the resolving phase of inflammation. In the present review we will summarize and discuss the current knowledge regarding the modulating effects ofω-3 PUFAs on the production of inflammatory cytokines and proresolving or protective lipid mediators in the context of inflammatory, metabolic, neurodegenerative, and neoplastic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparative aspects of the brain growth spurt
Dobbing, J., & Sands, J. (1979) · Early Human Development · doi:10.1016/0378-3782(79)90022-7 · Cited by 2,506 · cited 1×
“Most DHA and AA accumulation in the brain takes place during brain development in the perinatal period from the beginning of the third trimester of gestation to 2 years after birth in humans and from prenatal day 7 to postnatal day 21 in rats [48–50].”
BackgroundAβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · cited 1×
“Recent studies have analyzed lipidomic aspects in the context of nonalcoholic steatohepatitis (NASH) pathology [44, 45], demonstrating an increase in the ratio ofω-6 toω-3 PUFAs inNASH liver tissue as well as in the plasma levels of the AA metabolites 5-HETE, 8-HETE, and 15-HETE in the progression from normal to NASH.”
BackgroundMacrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241 · cited 12×
“On the other hand, tumor growth may be associated with the progressive inhibition of NF-𝜅B and in the progressive development ofM2 inflammation, characterized by low levels of TNF-𝛼, IL-1, and IL-12, and high levels of IL-10 and TGF-𝛽 [120].”
BackgroundInfluentialDocosahexaenoic acid: Membrane properties of a unique fatty acid
Stillwell, W., & Wassall, S. R. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(03)00101-4 · Cited by 872 · cited 1×
“On the whole, however, unifying routes of action have been identified to explain the beneficial effects of these FAs [3], and it has now become clear that, once they are incorporated in our cell membranes, they can chemically and physically alter that microenvironment and, thus, influence the activities of many membra…”
BackgroundTau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 2×
“Moreover, DHA enhances NPD1 synthesis and NPD1 reduces IL-1β-stimulated COX-2 expression, and DHA/NPD1 up regulates anti-apoptotic Bcl2 and Bfl-1 proteins and down-regulate proapoptotic BID, BAX, BAD, and caspase-3 proteins in human ARPE-19 cells [62, 77].”
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667 · cited 2×
“In humans, DHA levels do not change in the healthy hippocampus between the ages of 33 to 90 years [53], but, in AD patients, they are reduced by 53% to 8% of total fatty acids in the PE fraction compared to 17% in healthy agematched controls [53], and, in patients with mild AD, fish oil supplementation (600mg of EPA +…”
Background
Cited by
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials
Avallone, R., Vitale, G., & Bertolotti, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174256 · Cited by 218
Van Dael, P. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.2.137 · Cited by 138
“There is recent evidence that n-3 LCPUFA supplementation may have beneficial effects on neurodegenerative disorders [66,67], such as Parkinson's disease (PD) and Alzheimer's disease (AD) [68-71].”
BackgroundLai, J. S., Oldmeadow, C., Hure, A. J., McEvoy, M., Hiles, S. A., Boyle, M., & Attia, J. (2016) · Nutrition Research · doi:10.1016/j.nutres.2015.11.017 · Cited by 51
“Inverse associationswereobserved between fruit and MUFA intakes (both sex groups), n-3 PUFA intake and plasma lutein + zeaxanthin (in men), and depressive symptoms, whereas total fat and SFA intakes were positively associated with depressive symptoms.”
BackgroundInfluentialSerini, S., & Calviello, G. (2021) · Foods · doi:10.3390/foods10102306 · Cited by 14
Self-citation
Metadata
- Authors
- Calviello, G., Su, H.-M., Weylandt, K. H., Fasano, E., Serini, S., & Cittadini, A.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2035338017
- Cited by
- 81
- References
- 18
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Experimental Evidence ofω-3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic Diseases. https://app.cochat.ai/papers/10.1155/2013/743171
- The paper
- Calviello, G., Su, H.-M., Weylandt, K. H., Fasano, E., Serini, S., & Cittadini, A. (2013). Experimental Evidence ofω-3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic Diseases. BioMed Research International. https://doi.org/10.1155/2013/743171
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.